Daré Bioscience, Inc. to Present at the 2017 BIO Investor Forum
October 10, 2017 08:30 ET
|
Dare Bioscience, Inc.
SAN DIEGO, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s...
Daré Bioscience, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
September 07, 2017 08:30 ET
|
Dare Bioscience, Inc.
SAN DIEGO, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a healthcare company committed to the development and commercialization of innovative products in women’s...
Daré Bioscience, Inc. to Present at the Liolios 6th Annual Gateway Conference
August 30, 2017 08:30 ET
|
Dare Bioscience, Inc.
SAN DIEGO, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a healthcare company committed to the development and commercialization of innovative products in women’s...
Daré Bioscience, Inc. CEO Featured in San Diego Business Journal Article on Women Founders
August 15, 2017 08:30 ET
|
Dare Bioscience, Inc.
SAN DIEGO, Aug. 15, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE) and the CEO, Sabrina Martucci Johnson, were featured in a San Diego Business Journal article published on August 14,...
Daré Bioscience, Inc. Discusses Key Goals with Wall Street Analyzer
August 03, 2017 08:30 ET
|
Dare Bioscience, Inc.
SAN DIEGO, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE) discussed with Wall Street Analyzer key goals over the next twenty-four months, including the Ovaprene® clinical...
Daré Bioscience, Inc. announces Memorandum of Understanding with CONRAD for the conduct of the Ovaprene® postcoital test clinical trial
July 24, 2017 08:30 ET
|
Dare Bioscience, Inc.
SAN DIEGO, July 24, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE) announced today that it has entered into a memorandum of understanding with CONRAD to enter into an agreement in...
Daré Bioscience, Inc. trading on The NASDAQ Capital Market under the symbol “DARE”
July 20, 2017 08:30 ET
|
Dare Bioscience, Inc.
Company focused on the development and commercialization of women’s reproductive health productsDaré to Host Conference Call on Monday, July 24, 2017, at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific...
Daré Bioscience Announces Upcoming Presentation at LD Micro Invitational Conference
June 01, 2017 08:00 ET
|
Dare Bioscience, Inc.
SAN DIEGO, June 01, 2017 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc., a privately-held, clinical-stage healthcare company advancing products for women's reproductive health, today announced that...